CHRISTMAS ROM-COM MOVIE “EXES OF CHRISTMAS PAST” IS NOW STREAMING FOR THE HOLIDAYS

The holiday romance movieExes of Christmas Past is now available on major streaming platforms like Tubi, The Roku Channel, and Pluto TV, where it can be viewed for free anytime. The uplifting, family-friendly film is about an ambitious hotel manager who returns to her family's B&B for Christmas to find all three of her high […]

Info-Tech Research Group Named One of North America’s Fastest-Growing Companies by Deloitte for 2025 Technology Fast 500 List

Global IT research and advisory firm Info-Tech Research Group has been recognized by Deloitte's Fast 500 program, which recognizes the 500 fastest-growing companies across North America. The designation outlines the top companies based on three-year revenue growth. The inclusion on the Fast 500 list is a testament to Info-Tech's proprietary outcome-focused products, ongoing rapid international

Association of Clinical Research Professionals (ACRP) Honored as Bronze Winner in The 5th Annual Anthem Awards

Association of Clinical Research Professionals (ACRP) Honored as Bronze Winner in The 5th Annual Anthem Awards Recognition for its 2025 Clinical Trials Day Campaign GlobeNewswire November 19, 2025 Washington, DC, Nov. 19, 2025 (GLOBE NEWSWIRE) — The Association of Clinical Research Professionals (ACRP) proudly announced that it has been named a Bronze Winner by The

CWH Investors Have Opportunity to Join Camping World Holdings, Inc. Fraud Investigation with the Schall Law Firm

CWH Investors Have Opportunity to Join Camping World Holdings, Inc. Fraud Investigation with the Schall Law Firm GlobeNewswire November 19, 2025 LOS ANGELES, Nov. 19, 2025 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Camping World Holdings, Inc. (“Camping

2025 Learning Series Drives Conversations About Opioid Misuse

2025 Learning Series Drives Conversations About Opioid Misuse GlobeNewswire November 19, 2025 Millburn, NJ, Nov. 19, 2025 (GLOBE NEWSWIRE) — Healthcare professionals and members of the public from New Jersey and beyond received timely information and practical guidance in the fight against opioid misuse through the 2025 Knock Out Opioid Abuse Day Learning Series. The

Attain Partners Named 2025 NVTC Tech 100 Honoree

Professional Services firm recognized for innovation and impact in the Greater Washington region Attain Partners, a leading management, technology, and strategy consulting firm, is proud to announce its selection as a 2025 NVTC Tech 100 Honoree by the Northern Virginia Technology Council (NVTC). This marks the fifth consecutive year that Attain Partners has received this

Cellipont Bioservices and Ronawk Partner to Advance Scalable Expansion of High-Quality Mesenchymal Stem Cells and Biologics

Cellipont Bioservices, a leading cell therapy Contract Development and Manufacturing Organization (CDMO), today announced a strategic collaboration with Ronawk, developer of the Bio-OS™ biological operating system, to accelerate the scalable expansion of high-quality mesenchymal stem cells (MSCs). The partnership addresses key industry challenges in scalability, consistency, capital efficiency, and therapeutic readiness for advanced biologics and

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against James Hardie Industries plc (NYSE: JHX)

(NYSE:JHX), NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of James Hardie Industries plc (“James Hardie” or the “Company”) (NYSE: JHX) between May 20, 2025 and August 18,

The Biotech Sector is Seeing a Major Boost From Programmable Cell Therapies in Chronic Disease Care

(Other OTC:AVAI), Issued on behalf of Avant Technologies Inc. VANCOUVER, British Columbia, Nov. 19, 2025 (GLOBE NEWSWIRE) — USA News Group News Commentary – The autologous cell therapy market surpassed $10.1 billion in 2025 as biotechnology companies race to commercialize therapies that read, replace, and rewrite cellular behavior to combat age-related diseases and metabolic disorders.

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against James Hardie Industries plc (NYSE: JHX)

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against James Hardie Industries plc (NYSE: JHX) GlobeNewswire November 19, 2025 NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who

Scroll to Top